John B. Sanfilippo & Son, Inc. (JBSS) Stock Price & Analysis
John B. Sanfilippo & Son, Inc. (JBSS) is trading at USD 61.34, up 0.95% today, as of November 18, 2026 at 20:53 UTC (US market open; quotes may be delayed), according to Nexqual market data.
JBSS last closed at USD 60.76; today's session has ranged USD 60.54–61.77 on volume of 96,761 shares. Market capitalization is $717.22M, with a 52-week range of USD 50.73–92.08 (NMS). Source: Nexqual, retrieved November 18, 2026 at 20:53 UTC.
Also available as compact Markdown for AI agents: nexqual.com/JBSS.md
Key facts (JBSS)
- Last four reported quarters (through Sep 24, 2026): revenue $1.17B, net income $56.4M (4.8% margin), free cash flow $30.4M (SEC filings).
- Valuation: P/E 12.7x (avg 15.9x at the last 3 fiscal year-ends), EV/EBITDA 7.0x, net debt $47.6M.
- Analysts: Buy (mean 1.50 on a 1–5 scale) (2 analysts), mean target USD 94 (range 79–109).
- Total return with dividends: 1Y -6.1% vs S&P 500 +11.9%; 5Y -12.3% vs S&P 500 +66.7%.
- Next earnings: 2027-01-28 (date not yet confirmed by the company), EPS estimate USD 1.17, revenue estimate $309M.
- Dividend: USD 0.95 a year (yield 1.56%), paid semiannual; latest ex-dividend date 2026-08-17; annual dividends fell 8.4% a year 2022–2025.
- Short interest: 7.81% of float (as of 2026-10-30), 4.2 days to cover.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (JBSS)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $956M | $1000M | $1.07B | $1.11B | $1.18B | $1.17B |
| Gross profit | $200M | $212M | $214M | $203M | $211M | — |
| Operating income | $87.4M | $90.2M | $85.2M | $84.7M | $89.2M | $81.5M |
| Net income | $61.8M | $62.9M | $60.2M | $58.9M | $61.9M | $56.4M |
| EPS (diluted) | $5.33 | $5.40 | $5.15 | $5.03 | $5.26 | — |
| Free cash flow | $1.9M | $104M | $73.4M | -$20.2M | $35.7M | $30.4M |
| Gross margin | 20.9% | 21.2% | 20.1% | 18.4% | 18.0% | — |
| Operating margin | 9.1% | 9.0% | 8.0% | 7.7% | 7.6% | 7.0% |
| Net margin | 6.5% | 6.3% | 5.6% | 5.3% | 5.3% | 4.8% |
| Revenue growth | +11.3% | +4.6% | +6.7% | +3.8% | +6.2% | — |
| Cash + short-term investments | $415K | $1.9M | $484K | $585K | $1.1M | — |
| Total debt | $10.9M | $7.8M | $7.1M | $15.6M | $49.8M | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Sep 24, 2026) (JBSS)
P/E 12.7x · P/S 0.6x · EV/EBITDA 7.0x · EV/Sales 0.7x · P/FCF 23.6x · P/B 1.9x · FCF yield 4.24% · Earnings yield 7.86% · Dividends paid in those quarters ÷ market cap 7.35% · Net debt $47.6M · EV $765M
P/E at fiscal year-ends: Jun 2026 16.4x, Jun 2025 12.6x, Jun 2024 18.8x.
Analysts (JBSS)
Consensus Buy (mean 1.50 on a 1–5 scale), 2 analysts; mean target USD 94 (low 79, high 109).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | BWS Financial | Maintained | Buy | $109 |
| 2026-08-21 | BWS Financial | Maintained | Buy | $109 |
| 2026-08-20 | Freedom Broker | Upgrade | Hold → Buy | $95 → $91 |
Total return (dividends reinvested) (JBSS)
| 1Y (from 2025-11-18) | 5Y (from 2021-11-15) | |
|---|---|---|
| Total return | -6.1% | -12.3% |
| S&P 500 (SPY) | +11.9% | +66.7% |
| Per year | -6.1% | -2.6% |
| Volatility (annualized) | 32.1% | 29.6% |
| Max drawdown | -40.6% (Jul 2026→Nov 2026) | -50.9% (Jun 2023→Oct 2026) |
Dividends (JBSS)
Annual dividend rate USD 0.95 per share, yield 1.56% at the current price. Paid over the last 12 months: USD 4.50 in 3 payments (semiannual).
Most recent ex-dividend date: Aug 17, 2026; payment date: Sep 9, 2026. To receive a dividend, shares must be owned before the ex-dividend date.
Latest change: raised 33.3% to USD 2.00 per payment from USD 1.50, starting with the Aug 17, 2026 ex-dividend date.
Payout ratio 20% of earnings · 5-year average yield 0.95% · annual dividends fell 8.4% a year from 2022 to 2025.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-08-17 | USD 2.00 |
| 2026-04-27 | USD 1.50 |
| 2025-12-01 | USD 1.00 |
| 2025-08-19 | USD 1.50 |
| 2024-08-20 | USD 2.10 |
| 2024-05-31 | USD 1.00 |
| 2023-08-21 | USD 2.00 |
| 2023-05-31 | USD 1.50 |
Total by calendar year: 2022 USD 3.25 · 2023 USD 3.50 · 2024 USD 3.10 · 2025 USD 2.50.
Short interest (JBSS)
583,809 shares sold short, 7.81% of the float, as of Oct 30, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 30, 2026): 585,954 shares (-0.4%). Days to cover: 4.2 (short shares ÷ average daily volume).
JBSS earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Sep 30, 2026 | $1.11 | $1.53 | Miss −27.5% | — |
| — | Quarter ended Jun 30, 2026 | $0.71 | $1.17 | Miss −39.3% | — |
| — | Quarter ended Mar 31, 2026 | $1.43 | $1.16 | Beat +23.3% | — |
| — | Quarter ended Dec 31, 2025 | $1.53 | $1.36 | Beat +12.5% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
JBSS suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Walmart (WMT) | “Net sales to Walmart Inc. accounted for approximately 41% of our net sales for fiscal 2026, 40% of our net sales for fiscal 2025 and 39% of our net sales for fiscal 2024.” |
| Customer | Squirrel Brand | “We sell products through the consumer channel under our brand names, including the Fisher, Orchard Valley Harvest, Squirrel Brand, and Southern Style Nuts brands, as well as under our customers' private brands.” |
| Customer | Target (TGT) | “Net sales to Target Corporation accounted for approximately 12% of our net sales for fiscal 2026, 11% for fiscal 2025 and 13% for fiscal 2024.” |
| Competitor | PepsiCo (PEP) | “In the bar industry, we compete with, among others, General Mills (Nature Valley brand), PepsiCo, Inc. (Quaker brand), Mondelez (CLIF brand), Kellanova (Nutrigrain brand), Mars (KIND and Nature's Bakery brands) as well as regional bar manufacturers.” |
Quoted from the company's 10-K filed Aug 19, 2026.
JBSS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $1.17 | $1.51 | -22.6% | $309.0M | 2 |
| Next quarter (ends Mar 2027) | $1.35 | $1.60 | -15.8% | $291.7M | 2 |
| Current fiscal year (ends Jun 2027) | $4.75 | $6.05 | -21.5% | $1.20B | 2 |
| Next fiscal year (ends Jun 2028) | $4.83 | $5.67 | -14.8% | $1.24B | 1 |
JBSS options: expected move
Options price a move of about ±13.7% (±$8.35) by Mar 19, 2027, which includes earnings on Jan 28, 2027.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 2 | 32.1% | ±4.2% |
| Dec 18, 2026 | 30 | 31.0% | ±6.5% |
| Mar 19, 2027 | 121 | 30.1% | ±13.7% |
| Jun 17, 2027 | 211 | 28.4% | ±17.3% |
30-day implied volatility 29.1% vs 57.7% realized over the last 30 trading days. Put/call ratio (volume) 0.04. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of November 18, 2026 at 20:53 UTC)
| Price | USD 61.34 |
|---|---|
| Change | ▲ 0.95% (up) |
| Previous Close | USD 60.76 |
| Open | USD 60.56 |
| Day Range | USD 60.54 – 61.77 |
| 52-Week Range | USD 50.73 – 92.08 |
| Volume | 96,761 shares |
| Market Cap | $717.22M |
| Exchange | NMS |
Technical Analysis (JBSS)
Nexqual's technical model rates JBSS "SELL" based on 2 bullish and 4 bearish signals across 129 daily candles, as of November 18, 2026 at 20:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 51.45 (neutral) |
| vs SMA50 | Below (USD 64.2) |
| MACD | -1.67 (negative) |
Analyst Ratings (JBSS)
Wall Street analysts rate JBSS "Buy" based on 2 analysts, with a mean price target of USD 94 (range USD 79–109), per Nexqual as of November 18, 2026 at 20:53 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 94 |
| High Target | USD 109 |
| Low Target | USD 79 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (JBSS)
| Next Earnings Date | 2027-01-28 |
|---|---|
| Revenue Estimate | $308.97M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 1.11 vs est 1.53 ▼ miss |
| 2026-06-30 | USD 0.71 vs est 1.17 ▼ miss |
| 2026-03-31 | USD 1.43 vs est 1.16 ▲ beat |
| 2025-12-31 | USD 1.53 vs est 1.36 ▲ beat |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Financials & Fundamentals (JBSS)
| Total Revenue | $1.17B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -3.50% |
| Gross Margin | +17.68% |
| Operating Margin | +6.66% |
| Profit Margin | +4.84% |
| ROE | +15.37% |
| Debt / Equity | 0.4 |
| Current Ratio | 1.96 |
| Total Cash | $2.02M |
| Total Debt | $148.73M |
| Free Cash Flow (last four quarters to Sep 2026, SEC 10-Q / 10-K) | $30.41M (2.6% of revenue) |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Financial Health Score (JBSS)
Nexqual rates John B. Sanfilippo & Son, Inc.'s overall financial health "Mixed" across five dimensions, as of November 18, 2026 at 20:53 UTC.
| Growth | Mixed — Revenue +3.1% (last 4 quarters to Sep 2026 vs the 4 before, SEC), slow |
|---|---|
| Profitability | Mixed — Gross margin 18%, operating 7% (last 4 quarters to Sep 2026, SEC) |
| Balance Sheet | Solid — $2M cash and investments vs $50M debt (Sep 2026, SEC) |
| Cash Flow | Mixed — FCF $30M (last 4 quarters to Sep 2026, SEC), slim 2.6% margin |
| Efficiency | Solid — ROE 15%, ROA 8.4% (last 4 quarters, SEC) |
Ownership (JBSS)
| Insider Ownership | +2.30% |
|---|---|
| Institutional Ownership | +100.25% |
| Shares Outstanding | 9.10M |
| Float | 8.96M |
| Short % of Float | +7.81% |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
Leadership (JBSS)
John B. Sanfilippo & Son, Inc. is led by Jasper B. Sanfilippo, CEO & Director, per Nexqual as of November 18, 2026 at 20:53 UTC.
| CEO & Director | Jasper B. Sanfilippo |
|---|---|
| President & CFO | Frank S. Pellegrino |
| Senior Vice President of Human Resources | Julia A. Pronitcheva |
| Vice President of Regulatory Compliance | Brenda Cannon |
| Vice President of Food Safety, Quality & Regulatory Compliance | Michael D. Campagna |
Major Backers & Investors (JBSS)
Notable institutional backers of John B. Sanfilippo & Son, Inc. include Thrivent Financial For Lutherans, Thrivent Mutual Funds-Thrivent Small Cap Stock Fund, American Century Companies Inc, according to Nexqual as of November 18, 2026 at 20:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Thrivent Financial For Lutherans | 8.95% |
| Thrivent Mutual Funds-Thrivent Small Cap Stock Fund | 6.29% |
| American Century Companies Inc | 4.53% |
| DEUTSCHE DWS INVESTMENT TRUST-DWS Small Cap Core Fund | 2.75% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 16.26% |
| Vanguard Group | 8.01% |
| Dimensional Fund Advisors | 4.05% |
| State Street | 3.99% |
| Geode Capital | 2.85% |
| Deutsche Bank AG | 2.29% |
Source: Nexqual, November 18, 2026 at 20:53 UTC.
From John B. Sanfilippo & Son, Inc.'s Latest SEC 10-K Filing (filed 2026-08-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Through a deliberate strategy of focused capital expenditures and complementary acquisitions, we have built a generally vertically integrated nut processing operation that enables us to control almost every step of the process for pecans, peanuts and walnuts, including procurement from growers, shelling, processing, packaging and marketing.
- In recent years, we have developed Fisher recipe nuts among the leading brands in the category through strong marketing campaigns, merchandising, and promotional support to retailers.
- As discussed, we are generally vertically integrated with respect to pecans, peanuts and walnuts.
- We are one of the leading processors and distributors of peanuts, pecans, cashews, walnuts, almonds and other nuts in the United States.
Legal & Regulatory Risks (Item 1A, quoted)
- We are Subject to Government Regulation Which Could Materially and Adversely Affect Our Results of Operations
- Operational, Legal, Economic, Political and Social Risks of Doing Business in International Markets and Other Foreign Countries May Have a Material Adverse Effect on Our Results of Operations
- Litigation, Investigations or Other Legal Actions Could Materially and Adversely Affect Our Financial Condition and Results of Operations
- Inability to Protect Our Intellectual Property or Avoid Intellectual Property Disputes Could Materially and Adversely Affect Our Financial Condition and Results of Operations
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 90.27 | ▼ 0.93% |
| PPC | Pilgrim's Pride Corporation | USD 27.88 | ▼ 2.11% |
| CAG | ConAgra Brands, Inc. | USD 14.87 | ▲ 1.33% |
| LW | Lamb Weston Holdings, Inc. | USD 51.99 | ▼ 4.02% |
| CPB | The Campbell's Company | USD 24.31 | ▲ 3.07% |
| SFD | Smithfield Foods, Inc. | USD 19.17 | ▲ 1.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt